Immucell (ICCC) Other Operating Expenses (2010 - 2025)

Immucell (ICCC) has reported Other Operating Expenses for 16 consecutive years, with -$62319.0 the latest figure, recorded in Q3 2025.

• For the quarter ending Q3 2025, Other Operating Expenses changed N/A year-over-year to -$62319.0; the trailing twelve-month figure through Jun 2026 stood at -$55191.0 (down 112.31% YoY), and the FY2025 full-year result was $426587.0, changed N/A from the prior year.
• Other Operating Expenses eased to -$62319.0 in Q3 2025 per ICCC's latest filing, from $7128.0 in the prior quarter.
• Across five years, Other Operating Expenses topped out at $992556.0 in Q4 2022 and bottomed at -$1.0 million in Q2 2022.
• Historically, Other Operating Expenses has averaged $351910.6 across 5 years, with a median of $436982.0 in 2021.
• The widest YoY moves for Other Operating Expenses: up 9816.4% in 2024, down 19005.19% in 2024.
• Over 5 years, Other Operating Expenses stood at $889929.0 in 2021, then rose by 11.53% to $992556.0 in 2022, then fell by 17.64% to $817486.0 in 2023, then tumbled by 98.22% to $14557.0 in 2024, then tumbled by 528.1% to -$62319.0 in 2025.
• According to Business Quant data, Other Operating Expenses over the past three periods registered -$62319.0, $7128.0, and $426587.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.